Metabolic Profiles of Gastric Cancer Cell Lines with Different Degrees of Differentiation

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2020 Jan 16

PMID 31938177

Citations 6

Authors

Wenjun Jiang

Liya Zhou

Sanren Lin

Yuan Li

Shiyu Xiao

Jian Liu

Zhengpeng Li

Yan Cui

Jianzhong Zhang

Affiliations

Soon will be listed here.

Abstract

Gastric cancer is a commonly found malignant tumor, yet research on biomarkers of gastric cancer still face tremendous challenges. This study is the first to use gas chromatography-mass spectrometry (GC-MS) to measure and compare the metabolic profiles of gastric cancer cell lines with varying degrees of differentiation (MKN-28, SGC-7901, and AGS) with that of a normal gastric epithelial cell line (GES-1). OPLS-DA models were established to distinguish gastric cancer cell lines from a normal gastric epithelial cell line. In this study, we identified 278 metabolites, of which 111 show similarity scores greater than 700. Most notably, 6 metabolites (alanine, α-ketoisocaproic acid, proline, glyceric acid, pantothenic acid, and adenosine) showed varying expression levels between gastric cancer cell lines and a normal gastric epithelial cell line. These metabolites are potential biomarkers of gastric cancer and may be of great significance for the diagnosis, treatment and prognosis of gastric cancer patients.

Citing Articles

Recent Advances on the Role of B Vitamins in Cancer Prevention and Progression.

Frost Z, Bakhit S, Amaefuna C, Powers R, Ramana K Int J Mol Sci. 2025; 26(5).

PMID: 40076592 PMC: 11900642. DOI: 10.3390/ijms26051967.

The metabolites mainly composed of lipids in tongue coating are non-invasive potential biomarkers for chronic gastritis.

You Z, Lu J, Xu Y, Zhang R, Zhu Z, Wang Y Sci Rep. 2024; 14(1):17574.

PMID: 39079952 PMC: 11289369. DOI: 10.1038/s41598-024-68261-6.

DNA Framework-Based Programmable Atom-Like Nanoparticles for Non-Coding RNA Recognition and Differentiation of Cancer Cells.

Zhu F, Yang X, Ouyang L, Man T, Chao J, Deng S Adv Sci (Weinh). 2024; 11(23):e2400492.

PMID: 38569466 PMC: 11187905. DOI: 10.1002/advs.202400492.

Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect.

Bin Y, Hu H, Tian F, Wen Z, Yang M, Wu B Front Oncol. 2022; 11:745209.

PMID: 35096565 PMC: 8790521. DOI: 10.3389/fonc.2021.745209.

Metabolite Characteristics in Tongue Coating from Damp Phlegm Pattern in Patients with Gastric Precancerous Lesion.

Xu Y, Zhang R, Morris R, Cheng F, Wang Y, Zhu Z Evid Based Complement Alternat Med. 2021; 2021:5515325.

PMID: 34122594 PMC: 8189775. DOI: 10.1155/2021/5515325.

References

Chan E, Koh P, Mal M, Cheah P, Eu K, Backshall A . Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res. 2008; 8(1):352-61. DOI: 10.1021/pr8006232. View

Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J . Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006; 66(22):10795-804. DOI: 10.1158/0008-5472.CAN-06-0755. View

Elshimali Y, Khaddour H, Sarkissyan M, Wu Y, Vadgama J . The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients. Int J Mol Sci. 2013; 14(9):18925-58. PMC: 3794814. DOI: 10.3390/ijms140918925. View

Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H . Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009; 69(11):4918-25. DOI: 10.1158/0008-5472.CAN-08-4806. View

Ong E, Zou L, Li S, Cheah P, Eu K, Ong C . Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis. Mol Cell Proteomics. 2010; . DOI: 10.1074/mcp.M900551-MCP200. View

Storey J, Tibshirani R . Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003; 100(16):9440-5. PMC: 170937. DOI: 10.1073/pnas.1530509100. View

Hsu W, Chen C, Huang Y, Tsai F, Jeng L, Lai C . Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese. PLoS One. 2013; 8(12):e81701. PMC: 3868621. DOI: 10.1371/journal.pone.0081701. View

Kuligowski J, Sanjuan-Herraez D, Vazquez-Sanchez M, Brunet-Vega A, Pericay C, Ramirez-Lazaro M . Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry. J Proteome Res. 2016; 15(8):2729-38. DOI: 10.1021/acs.jproteome.6b00281. View

Liang Q, Wang C, Li B . Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer. Appl Biochem Biotechnol. 2015; 176(8):2170-84. DOI: 10.1007/s12010-015-1706-z. View

10.

Kind T, Wohlgemuth G, Lee D, Lu Y, Palazoglu M, Shahbaz S . FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem. 2009; 81(24):10038-48. PMC: 2805091. DOI: 10.1021/ac9019522. View

11.

Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, Miura T . Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One. 2011; 6(9):e24143. PMC: 3168486. DOI: 10.1371/journal.pone.0024143. View

12.

Chen Y, Zhang Y, Pan F, Liu J, Wang K, Zhang C . Breath Analysis Based on Surface-Enhanced Raman Scattering Sensors Distinguishes Early and Advanced Gastric Cancer Patients from Healthy Persons. ACS Nano. 2016; 10(9):8169-79. DOI: 10.1021/acsnano.6b01441. View

13.

Allard W, Matera J, Miller M, Repollet M, Connelly M, Rao C . Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004; 10(20):6897-904. DOI: 10.1158/1078-0432.CCR-04-0378. View

14.

Slyshenkov V, Omelyanchik S, Moiseenok A, Trebukhina R, Wojtczak L . Pantothenol protects rats against some deleterious effects of gamma radiation. Free Radic Biol Med. 1998; 24(6):894-9. DOI: 10.1016/s0891-5849(97)00378-x. View

15.

Kim H, Lee K, Kim S, Kwon Y, Chun Y, Choi H . Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials. Oncotarget. 2016; 7(41):67111-67128. PMC: 5341861. DOI: 10.18632/oncotarget.11560. View

16.

Paterlini-Brechot P, Benali N . Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007; 253(2):180-204. DOI: 10.1016/j.canlet.2006.12.014. View

17.

Slyshenkov V, Moiseenok A, Wojtczak L . Noxious effects of oxygen reactive species on energy-coupling processes in Ehrlich ascites tumor mitochondria and the protection by pantothenic acid. Free Radic Biol Med. 1996; 20(6):793-800. DOI: 10.1016/0891-5849(95)02210-4. View

18.

Urayama S, Zou W, Brooks K, Tolstikov V . Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun Mass Spectrom. 2010; 24(5):613-20. DOI: 10.1002/rcm.4420. View

19.

Wang H, Zhang H, Deng P, Liu C, Li D, Jie H . Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR. BMC Cancer. 2016; 16:371. PMC: 4928316. DOI: 10.1186/s12885-016-2356-4. View